Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: Other
Life Threatening? No
Write-up: Case of adverse event received from health care professional via Health Authority on 05-Nov-2013 under the reference number DK-DKMA-ADR 22271499 and DK-DKMA-EFO7164. The primary reporter was a physician. Case is medically confirmed. A 13 year old female patient (weight: 58 kg; height: 166 cm), with no medical history reported, had received the primary dose of GARDASIL (batch number not reported) via intramuscular route of administration in not reported site of administration on 04-Nov-2008 and later on a non-specified date in Jan-2009 she developed air hunger, headache, chest pain, muscle pain and joint pain. Blood tests, pediatric examination for asthma, neurological examination, CT-scan and MRI-scan of the cerebrum was performed on a non-specified date (lab results not reported). The patient had no other medications. The patient received the second and third dose of GARDASIL (batch number not reported) via intramuscular route of administration in not reported site of administration on 24-Mar-2009 and 04-Aug-2009 respectively. At the time of reporting, the outcome was recovering from all reported adverse events.
Copyright © 2018 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166